Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholder's Equity (Unaudited)

v3.24.1.u1
Consolidated Statements of Stockholder's Equity (Unaudited) - USD ($)
$ in Thousands
Total
February 2024 Private Placement [Member]
November 2022 Private Placement [Member]
Common Stock [Member]
Common Stock [Member]
February 2024 Private Placement [Member]
Additional paid-in capital [Member]
Additional paid-in capital [Member]
February 2024 Private Placement [Member]
Additional paid-in capital [Member]
November 2022 Private Placement [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated deficit [Member]
Beginning Balance at Dec. 31, 2022 $ 8,303     $ 87   $ 144,148     $ 4 $ (135,936)
Beginning Balance, Shares at Dec. 31, 2022       17,897,029            
Stock-based compensation expense 1,085         1,085        
Shares issued on exercise of warrants 77         77        
Shares issued on exercise of warrants, Shares       33,333            
Financing costs     $ (30)         $ (30)    
Net loss (8,992)                 (8,992)
Ending Balance at Mar. 31, 2023 443     $ 87   145,280     4 (144,928)
Ending Balance, Shares at Mar. 31, 2023       17,930,362            
Beginning Balance at Dec. 31, 2023 (1,448)     $ 90   164,209     4 (165,751)
Beginning Balance, Shares at Dec. 31, 2023       21,165,760            
Stock-based compensation expense 1,288         1,288        
Shares issued, Shares         13,086,151          
Shares issued   $ 56,110     $ 13   $ 56,097      
Net loss (6,494)                 (6,494)
Ending Balance at Mar. 31, 2024 $ 49,456     $ 103   $ 221,594     $ 4 $ (172,245)
Ending Balance, Shares at Mar. 31, 2024       34,251,911